Ardelyx, Inc.
Ardelyx, Inc. (ARDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARDX · as of Jun 8, 2026
Key Statistics
Explore Ardelyx, Inc. Data
ardx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 100.0%
The ARDX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +206.26% upside from the current price of $5.55.
Competitors & Peers
ardx competitorsARDX
BCRX
MAZE
NTLA
PHVS
STOKStock Performance
Full HistoryAbout Ardelyx, Inc.
Ardelyx, Inc. a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The …
what is ardelyx, inc. · ardx stock overview · ardelyx, inc. company profile · who is ardelyx, inc. ceo · ardx NASDAQ · ardelyx, inc. headquarters · ardelyx, inc. business segments
About Stock Overview & Key Data
Ardelyx, Inc. (ARDX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2014. As of the latest trading session, ARDX stock price is $5.55, with a market capitalization of $1.4B. The stock has returned +49.07% over the past 12 months and -3.86% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Ardelyx, Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Ardelyx, Inc. reported revenue of $407.3M and net income of -$61.6M. For detailed data — including Ardelyx, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ardelyx, Inc. (ARDX) stock price is $5.55. The stock is traded on NASDAQ under the ticker symbol ARDX. The 52-week range is $3.49 – $8.40.